中老年人群幽门螺杆菌感染对非酒精性脂肪肝及冠状动脉粥样硬化影响的关联性分析

doi:10.3877/cma.j.issn.2095-2015.2024.02.007

目的

评估中老年人群幽门螺杆菌（Hp）感染对非酒精性脂肪肝（NAFLD）及冠状动脉粥样硬化（CA）的影响及相关性分析。

方法

选取2018年8月至2022年7月于上海中医药大学附属曙光医院健康体检的中老年受检者234例作为研究对象，根据是否存在Hp感染，将受检者分为Hp未感染组和Hp感染组。比较两组相关临床资料、脂肪肝水平、冠状动脉钙化水平和血液生化指标水平；通过Logistic多因素回归分析，探究NAFLD及CA与Hp感染的关系；通过Spearman检验探究NAFLD及CA的相关性。

结果

Hp感染组受检者体重指数（BMI）、年龄、高血压比例、糖尿病比例、高脂血症比例、血糖、丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）、总胆红素（TBiL）、直接胆红素（DBiL）、总胆固醇（TC）、三酰甘油（TG）、低密度脂蛋白（LDL）、肿瘤坏死因子-α（TNF-α）、白细胞介素（IL）-6和IL-12显著高于Hp未感染组（P<0.05），高密度脂蛋白（HDL）和IL-10显著低于Hp未感染组（P<0.05）；Hp感染组NAFLD及CA的发病率和严重程度显著高于Hp未感染组（P<0.05）。多因素Logistic回归分析显示，BMI、ALT、TBiL、TNF-α、IL-10、NAFLD和CA是影响受检者Hp感染的独立危险因素；Spearman检验显示，Hp感染组和未感染组的NAFLD和CA严重程度呈正相关。

结论

中老年人群Hp感染与NAFLD和CA具有较强的关联性，Hp的肝脏和心血管并发症应在临床实践中提高重视。

关键词: 幽门螺杆菌, 非酒精性脂肪肝, 冠状动脉粥样硬化, 中老年人

Objective

To evaluate the effect of Helicobacter pylori (Hp) infection on nonalcoholic fatty liver disease (NAFLD) and coronary atherosclerosis (CA) in middle-aged and elderly people and analyze the correlation.

Methods

A total of 234 middle-aged and elderly patients who underwent physical examinations between August 2018 and July 2022 were selected as the research subjects. Based on the presence of Hp infection, the subjects were divided into Hp uninfected group and Hp infected group. The clinical data, fatty liver levels, coronary artery calcification levels, and blood biochemical indicators levels between the two groups were compared. The relationship between NAFLD, CA, and Hp infection through Logistic multiple factor regression analysis was explored. The correlation between NAFLD and CA through Spearman test was explored.

Results

Body mass index (BMI), age, proportion of hypertension, proportion of diabetes, proportion of hyperlipidemia, blood glucose, alanine aminotransferase (ALT), aspartic transaminase (AST), total bilirubin (TBiL), direct bilirubin (DBiL), total cholesterol (TC), triacylglycerol (TG), low density lipoprotein (LDL), tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and IL-12 in Hp infected group were significantly higher than those in Hp uninfected group, while high-density lipoprotein (HDL) and IL-10 in Hp infected group were significantly lower than those in Hp uninfected group (P<0.05). The incidence rate and severity of NAFLD and CA in Hp infection group were significantly higher than those in Hp uninfected group (P<0.05). Multivariate Logistic regression analysis showed that BMI, ALT, TBiL, TNF-α, IL-10, NAFLD, and CA were independent risk factors affecting Hp infection in subjects. Spearman test showed a positive correlation between NAFLD and CA severity in the Hp infected and non-infected groups.

Conclusion

There is a strong correlation between Hp infection and NAFLD and CA in the middle-aged and elderly population. The liver and cardiovascular complications of Hp should be given more attention in clinical practice.

Key words: Helicobacter pylori, Non alcoholic fatty liver disease, Coronary atherosclerosis, Middle aged and elderly population

表1 两组受检者的临床资料和血液生化指标的比较

组别	例数	年龄(岁,±s)	男/女(例)	体重指数(kg/m²,±s)	高血压[例(%)]	糖尿病[例(%)]	高脂血症[例(%)]	血糖(mmol/L,±s)
Hp未感染组	129	57.25±8.09	58/71	25.06±2.95	52(40.3)	49(38.0)	35(27.1)	5.82±0.51
Hp感染组	105	58.54±9.43	46/59	23.16±2.81	54(51.4)	53(50.5)	41(39.0)	6.81±0.76
t/χ²		1.278	0.055	14.649	4.824	5.798	5.211	4.021
P		0.692	0.884	0.008	0.03	0.02	0.022	0.041
组别	例数	ALB(g/L,±s)	ALT(U/L,±s)	AST(U/L,±s)	TbiL(μmol/L,±s)	DbiL(μmol/L,±s)	TC(mmol/L,±s)	TG(mmol/L,±s)
Hp未感染组	129	42.65±3.24	32.14±1.95	21.85±0.53	11.78±4.34	3.35±1.24	4.09±0.96	1.67±84.02
Hp感染组	105	40.26±2.38	43.65±2.21	31.34±0.34	15.71±4.68	5.91±1.28	5.68±1.23	2.78±87.64
t/χ²		1.048	9.342	6.340	10.324	5.357	8.325	6.672
P		0.358	0.007	0.012	0.001	0.031	0.012	0.034
组别	例数	LDL(mmol/L,±s)	HDL(mmol/L,±s)	TNF-α(pg/mL,±s)	IL-1β(μg/L,±s)	IL-6(pg/mL,±s)	IL-10(pg/mL,±s)	IL-12(pg/mL,±s)
Hp未感染组	129	2.57±2.35	1.98±0.25	24.31±6.02	0.95±0.17	5.95±4.02	11.31±4.16	42.29±9.05
Hp感染组	105	3.45±2.68	1.24±0.39	39.95±8.47	1.12±0.29	11.68±4.92	8.29±3.42	63.25±12.85
t/χ²		4.967	4.157	25.315	3.345	10.325	13.295	7.381
P		0.045	0.047	<0.001	0.116	0.011	0.006	0.024

表1 两组受检者的临床资料和血液生化指标的比较

组别	例数	年龄(岁,±s)	男/女(例)	体重指数(kg/m²,±s)	高血压[例(%)]	糖尿病[例(%)]	高脂血症[例(%)]	血糖(mmol/L,±s)
Hp未感染组	129	57.25±8.09	58/71	25.06±2.95	52(40.3)	49(38.0)	35(27.1)	5.82±0.51
Hp感染组	105	58.54±9.43	46/59	23.16±2.81	54(51.4)	53(50.5)	41(39.0)	6.81±0.76
t/χ²		1.278	0.055	14.649	4.824	5.798	5.211	4.021
P		0.692	0.884	0.008	0.03	0.02	0.022	0.041
组别	例数	ALB(g/L,±s)	ALT(U/L,±s)	AST(U/L,±s)	TbiL(μmol/L,±s)	DbiL(μmol/L,±s)	TC(mmol/L,±s)	TG(mmol/L,±s)
Hp未感染组	129	42.65±3.24	32.14±1.95	21.85±0.53	11.78±4.34	3.35±1.24	4.09±0.96	1.67±84.02
Hp感染组	105	40.26±2.38	43.65±2.21	31.34±0.34	15.71±4.68	5.91±1.28	5.68±1.23	2.78±87.64
t/χ²		1.048	9.342	6.340	10.324	5.357	8.325	6.672
P		0.358	0.007	0.012	0.001	0.031	0.012	0.034
组别	例数	LDL(mmol/L,±s)	HDL(mmol/L,±s)	TNF-α(pg/mL,±s)	IL-1β(μg/L,±s)	IL-6(pg/mL,±s)	IL-10(pg/mL,±s)	IL-12(pg/mL,±s)
Hp未感染组	129	2.57±2.35	1.98±0.25	24.31±6.02	0.95±0.17	5.95±4.02	11.31±4.16	42.29±9.05
Hp感染组	105	3.45±2.68	1.24±0.39	39.95±8.47	1.12±0.29	11.68±4.92	8.29±3.42	63.25±12.85
t/χ²		4.967	4.157	25.315	3.345	10.325	13.295	7.381
P		0.045	0.047	<0.001	0.116	0.011	0.006	0.024

表2 两组受检者非酒精性脂肪肝和冠状动脉粥样硬化严重程度的比较[例（%）]

组别	例数	非酒精性脂肪肝				冠状动脉粥样硬化
组别	例数	无	轻度	中度	重度	无	轻度	中度	重度
Hp未感染组	129	57(44.2)	38(29.5)	24(18.6)	10(7.7)	66(51.2)	33(25.5)	18(14.0)	12(9.3)
Hp感染组	105	24(22.9)	33(31.4)	28(26.7)	20(19.0)	36(34.3)	23(21.9)	26(24.8)	20(19.0)
χ²		18.442				13.993
P		<0.001				0.003

表2 两组受检者非酒精性脂肪肝和冠状动脉粥样硬化严重程度的比较[例（%）]

组别	例数	非酒精性脂肪肝				冠状动脉粥样硬化
组别	例数	无	轻度	中度	重度	无	轻度	中度	重度
Hp未感染组	129	57(44.2)	38(29.5)	24(18.6)	10(7.7)	66(51.2)	33(25.5)	18(14.0)	12(9.3)
Hp感染组	105	24(22.9)	33(31.4)	28(26.7)	20(19.0)	36(34.3)	23(21.9)	26(24.8)	20(19.0)
χ²		18.442				13.993
P		<0.001				0.003

表3 影响受检者Hp感染的多因素Logistic回归分析

变量	β	标准误	Wald χ²	P	OR	95% CI
BMI	0.634	1.102	6.337	0.026	1.238	1.116~2.368
ALT	0.908	0.729	5.648	0.030	1.968	1.438~2.529
TBiL	0.982	1.326	9.624	0.008	2.465	1.530~4.395
TNF-α	0.799	0.946	10.062	0.004	3.485	2.945~6.973
IL-10	0.519	1.062	5.946	0.035	0.735	0.327~0.824
NAFLD	0.782	1.165	7.258	0.013	1.826	1.329~3.026
CA	0.725	0.912	5.468	0.039	1.395	1.068~1.882

表3 影响受检者Hp感染的多因素Logistic回归分析

变量	β	标准误	Wald χ²	P	OR	95% CI
BMI	0.634	1.102	6.337	0.026	1.238	1.116~2.368
ALT	0.908	0.729	5.648	0.030	1.968	1.438~2.529
TBiL	0.982	1.326	9.624	0.008	2.465	1.530~4.395
TNF-α	0.799	0.946	10.062	0.004	3.485	2.945~6.973
IL-10	0.519	1.062	5.946	0.035	0.735	0.327~0.824
NAFLD	0.782	1.165	7.258	0.013	1.826	1.329~3.026
CA	0.725	0.912	5.468	0.039	1.395	1.068~1.882

[1]	Sun Y, Zhang J. Helicobacter pylori recrudescence and its influencing factors[J]. J Cell Mol Med, 2019, 23(12): 7919-7925.
[2]	Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022, 37(3): 464-470.
[3]	Baradaran A, Dehghanbanadaki H, Naderpour S, et al. The association between Helicobacter pylori and obesity: a systematic review and meta-analysis of case-control studies[J]. Clin Diabetes Endocrinol, 2021, 7(1): 15.
[4]	Gravina AG, Zagari RM, De Musis C, et al. Helicobacter pylori and extragastric diseases: A review[J]. World J Gastroenterol, 2018, 24(29): 3204-3221.
[5]	中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南[J/OL]. 中国肝脏病杂志(电子版), 2010, 2(4): 43-48.
[6]	王伟民, 霍勇, 葛均波. 冠状动脉钙化病变诊治中国专家共识(2021版)[J]. 中国介入心脏病学杂志, 2021, 29(5): 251-259.
[7]	Li M, Sun Y, Yang J, et al. Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta-analysis[J]. Helicobacter, 2020, 25(5): e12729.
[8]	Franceschi F, Covino M, Roubaud Baudron C. Review: Helicobacter pylori and extragastric diseases[J]. Helicobacter, 2019, 24 Suppl 1: e12636.
[9]	Abo-Amer YE, Sabal A, Ahmed R, et al. Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease(NAFLD) in a Developing Country: A Cross-Sectional Study[J]. Diabetes Metab Syndr Obes, 202, 13: 619-625.
[10]	Doğan Z, Filik L, Ergül B, et al. Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study[J]. Eur J Gastroenterol Hepatol, 2013, 25(1): 107-10.
[11]	Lee M, Baek H, Park JS, et al. Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study[J]. PLoS One, 2018, 13(3): e0193646.
[12]	王明虎, 仲玉, 刘景新, 等. 中老年体检人群幽门螺杆菌感染与冠状动脉钙化积分相关性研究[J]. 中国临床医生杂志, 2023, 51(4): 422-425.
[13]	谢海燕. 脂肪肝临床诊断中ALT、AST肝功能指标与TG、TC血脂指标的临床价值[J]. 黔南民族医专学报, 2022, 35(4): 259-261.
[14]	Xu X, Li W, Qin L, et al. Relationship between Helicobacter pylori infection and obesity in Chinese adults: A systematic review with meta-analysis[J]. PLoS One, 2019, 14(9): e0221076.
[15]	Mommersteeg MC, Simovic I, Yu B, et al. Autophagy mediates ER stress and inflammation in Helicobacter pylori-related gastric cancer[J]. Gut Microbes, 2022, 14(1): 2015238.
[16]	Yu YY, Tong YL, Wu LY, et al. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial[J]. Sci Rep, 2022, 12(1): 19530.

[1]	李梦声, 韩中博. 胃癌的高危可控因素——幽门螺杆菌感染[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 145-150.
[2]	单秋洁, 孙立柱, 徐宜全, 王之霞, 徐妍, 马浩, 刘田田. 中老年食管癌患者调强放射治疗期间放射性肺损伤风险模型构建及应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 388-393.
[3]	李运林, 娄冬华. 滨海县非酒精性脂肪肝发病与消退的影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 354-358.
[4]	刘立业, 赵德芳. 非酒精性脂肪肝患者血清细胞因子信号转导抑制因子3、肝X受体α水平与CT影像学特征的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 211-215.
[5]	赵军, 李超杰, 李佳. 雷贝拉唑联合康复新液对治疗幽门螺杆菌阳性的十二指肠溃疡的疗效[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 254-258.
[6]	石小琼, 殷国建. 不同观察时间对幽门螺杆菌快速尿素酶试验诊断准确性的研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 150-154.
[7]	张洪, 王宏宇. 神经酰胺与心脏和血管疾病关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(11): 1202-1205.
[8]	李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[9]	孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
[10]	董青, 丁飞, 郭浩, 李峰. Nesfatin-1/NUCB2在幽门螺杆菌感染相关早期胃癌患者中的表达及临床意义[J]. 中华临床医师杂志(电子版), 2023, 17(07): 783-789.
[11]	魏红涛, 普布仓决, 格桑央宗, 黎燕, 益西旺扎, 李鹏. 拉萨地区上消化道溃疡患者幽门螺杆菌感染及治疗分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 662-665.
[12]	蒋蔚茹, 徐三荣. 要努力弄清"慢性胃炎"的临床意义[J]. 中华诊断学电子杂志, 2023, 11(04): 266-270.
[13]	高明生, 张盼盼, 包楠迪, 孟繁森, 李婷婷, 徐世平. 一种新型乳链菌素混合物体外杀灭幽门螺杆菌的实验研究[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 258-263.
[14]	贺欢, 孔文洁, 高峰. 重度反流性食管炎合并消化性溃疡的临床特征分析[J]. 中华胃食管反流病电子杂志, 2023, 10(03): 135-138.
[15]	张娜, 鲁志宏, 张盛军, 陈启众, 俞永涛, 陈申思, 钱海权, 刘轲. 腹腔镜袖状胃切除术治疗肥胖合并非酒精性脂肪肝患者肝纤维化的短期疗效分析[J]. 中华肥胖与代谢病电子杂志, 2023, 09(04): 261-266.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Correlation analysis of the influence of Helicobacter pylori infection on nonalcoholic fatty liver disease and coronary atherosclerosis in middle-aged and elderly people

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Correlation analysis of the influence of Helicobacter pylori infection on nonalcoholic fatty liver disease and coronary atherosclerosis in middle-aged and elderly people